38,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
19 °P sammeln
  • Broschiertes Buch

This particular cohort of non responders did not have pre-treatment HCV genotyping carried out, as Genotype 3 is the most common genotype in Pakistan and the facility is not accessible to all. A crossectional study was carried out to determine HCV genotypes in patients with either non response or relapse after six months of combined treatment with Interferon and Ribavirin. The major HCV-genotypes detected in patients with non-response were 1a in 16 (41%) patients, 3a in 15(38.5%) The pool of non-responder patients comprises mostly of patients with genotype 1 and 3. The patients with Genotype 1…mehr

Produktbeschreibung
This particular cohort of non responders did not have pre-treatment HCV genotyping carried out, as Genotype 3 is the most common genotype in Pakistan and the facility is not accessible to all. A crossectional study was carried out to determine HCV genotypes in patients with either non response or relapse after six months of combined treatment with Interferon and Ribavirin. The major HCV-genotypes detected in patients with non-response were 1a in 16 (41%) patients, 3a in 15(38.5%) The pool of non-responder patients comprises mostly of patients with genotype 1 and 3. The patients with Genotype 1 were given suboptimal treatment of six months. HCV genotyping is of utmost importance in determining the rationale for predicting treatment efficacy and virologic monitoring in these non-responders.
Autorenporträt
Dr. Sabeen Khurshid Zaidi is a Clinical Virologist and Infection Control Officer in a leading Tertiary Cardiac Center in Pakistan. Her areas of interest include Moleculer Virology, Emerging viral diseases, Biosafety and Infection control. Apart from her avid interest in medical virology she is a busy mother of three adorable children and a poet.